Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20683,853,1.01 [0.97-1.06],0.5543839858221682
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20630,167,1.09 [0.96-1.23],0.2017676467311847
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22320,167,1.06 [0.95-1.18],0.3096896401978254
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15738,638,1.10 [1.03-1.17],0.0057703673745431
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22262,109,1.08 [0.94-1.25],0.2848947062665001
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21382,74,1.03 [0.89-1.19],0.6942200854674371
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23463,108,1.08 [0.93-1.25],0.301289165722534
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23456,71,1.06 [0.89-1.28],0.5107622494006181
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20842,50,0.96 [0.75-1.24],0.7597787494571051
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22912,104,1.00 [0.86-1.15],0.9695797327890396
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22872,64,1.04 [0.89-1.23],0.6027067406698486
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23529,68,1.16 [1.02-1.33],0.0252152305923182
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23504,83,0.92 [0.78-1.09],0.3507071546776459
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23501,80,0.93 [0.79-1.10],0.3872667210250812
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Mycoses,23213,58,1.06 [0.91-1.23],0.4850586813138495
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22526,370,0.98 [0.90-1.06],0.5989099313211883
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22270,114,0.92 [0.78-1.08],0.2998834590203114
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22413,257,0.98 [0.88-1.08],0.645188959758362
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19236,46,0.82 [0.52-1.29],0.383800898056158
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19245,55,0.82 [0.61-1.10],0.1783194478515191
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19419,229,1.02 [0.89-1.17],0.737813212833405
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19426,236,1.01 [0.89-1.16],0.8346402164549803
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19765,575,0.85 [0.78-0.94],0.000874450693921
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19235,45,0.77 [0.55-1.09],0.1400977539120317
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21126,872,1.03 [0.99-1.07],0.1782042349322973
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22622,250,0.83 [0.70-0.99],0.0366134863357669
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23228,95,0.79 [0.59-1.06],0.1164173017657839
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23609,82,0.73 [0.52-1.03],0.0713846680833604
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Rectum,23429,54,0.95 [0.70-1.28],0.7357506015931498
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23611,58,0.97 [0.73-1.30],0.8533285034947979
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Stomach,23653,44,1.04 [0.78-1.40],0.7852348589706373
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm,23466,238,0.92 [0.83-1.03],0.1394434108476929
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23610,97,0.93 [0.79-1.10],0.3907311187287446
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23610,89,0.82 [0.65-1.04],0.0955874897802235
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23546,60,1.03 [0.87-1.23],0.7005654336392642
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma, any site",23548,59,1.03 [0.87-1.23],0.7298978704805574
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi,23464,230,1.05 [0.98-1.13],0.1469722563810471
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23613,108,1.07 [0.97-1.19],0.1829787799202528
RLN2,Prorelaxin H2,Chapter II Neoplasms,Other benign neoplasms of skin,23520,194,1.03 [0.93-1.13],0.6005687979363783
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of breast,23599,120,1.01 [0.90-1.12],0.9168275796857492
RLN2,Prorelaxin H2,Chapter II Neoplasms,Leiomyoma of uterus,23171,866,0.92 [0.87-0.97],0.0007987337492369
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22483,238,1.04 [0.97-1.13],0.283000221918931
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22255,374,1.03 [0.97-1.10],0.3038527448624195
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22255,374,1.03 [0.97-1.10],0.3038527448624195
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20943,338,1.04 [0.96-1.13],0.3775355984721096
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23143,83,0.60 [0.43-0.84],0.0029708731834614
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23362,83,0.87 [0.74-1.02],0.0935455801520638
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19667,749,1.05 [0.98-1.13],0.1652041491427709
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21702,756,1.03 [0.97-1.09],0.3016150877307512
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22073,96,1.08 [0.95-1.23],0.2531549385462981
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22768,47,1.05 [0.81-1.35],0.7177363388579412
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22063,86,1.07 [0.93-1.23],0.3710784000595691
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22321,344,1.10 [1.00-1.21],0.0420924856838563
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22311,334,1.10 [1.00-1.21],0.0578962709971393
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21898,164,1.05 [0.92-1.20],0.4709522498691403
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21900,161,1.05 [0.92-1.20],0.5072940747934949
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19504,586,0.99 [0.89-1.09],0.7998018401279766
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18984,66,1.06 [0.82-1.37],0.6704416857102979
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19464,546,0.99 [0.89-1.10],0.7999411923652222
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18966,48,1.17 [0.99-1.39],0.0698046236297807
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18975,57,1.01 [0.82-1.26],0.9047317442273034
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Any mental disorder,19951,513,0.96 [0.91-1.02],0.234999931066937
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19534,96,0.94 [0.82-1.08],0.3953881668854379
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23438,61,0.91 [0.77-1.08],0.2942020751946024
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23474,36,0.84 [0.65-1.08],0.1745210646497428
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22404,31,1.01 [0.83-1.24],0.8862708857251419
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23609,31,1.02 [0.83-1.24],0.8672372755252272
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19469,31,1.01 [0.83-1.23],0.9358139061356304
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Alcohol dependence,22394,21,0.79 [0.54-1.15],0.2184212554779196
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Smoking dependency,22313,31,0.76 [0.49-1.17],0.2095721746036772
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19476,38,0.94 [0.77-1.16],0.581736255306319
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19753,315,1.00 [0.93-1.07],0.9296528244485692
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Depression,21939,281,0.98 [0.91-1.06],0.6371606024317185
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Depression or dysthymia,19574,243,0.99 [0.92-1.08],0.8768373543438501
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19566,128,0.92 [0.81-1.05],0.1964725563280486
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22010,65,0.97 [0.80-1.17],0.7240510871047874
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Neurological diseases,20471,1388,0.99 [0.95-1.03],0.5124803935488054
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18729,158,0.87 [0.77-1.00],0.0441502518766255
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23481,129,0.89 [0.77-1.02],0.093661195467518
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22529,363,0.98 [0.90-1.05],0.5411866490952977
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Epilepsy,22279,113,0.97 [0.86-1.10],0.6311610918894772
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Migraine,22274,108,0.92 [0.80-1.07],0.289984317452385
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23273,101,0.89 [0.76-1.05],0.1727660752316568
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23059,50,1.16 [0.93-1.44],0.1980053991716959
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other sleep disorders,22254,88,1.00 [0.84-1.19],0.9841617503307144
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Sleep apnoea,23298,62,0.96 [0.78-1.19],0.7319487021199554
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22464,718,0.98 [0.92-1.04],0.4143891685239239
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21850,104,0.96 [0.83-1.10],0.539660583460515
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22197,451,1.00 [0.93-1.08],0.9959969158244606
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23431,65,0.99 [0.84-1.17],0.8952205081622908
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hemiplegia,23414,48,0.99 [0.82-1.20],0.9393201443140784
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other neurological diseases,23235,101,1.01 [0.89-1.15],0.8482615057984407
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23020,371,0.94 [0.86-1.03],0.1910933556025932
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22861,212,0.99 [0.88-1.11],0.861269087894063
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22712,63,0.84 [0.66-1.05],0.1318124066488992
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22759,110,0.98 [0.84-1.15],0.8254722433426267
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22742,93,0.97 [0.81-1.17],0.7723386705818107
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20060,145,1.06 [0.85-1.31],0.6272306902917648
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20271,356,1.03 [0.91-1.17],0.627953520396079
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22765,153,1.00 [0.85-1.17],0.9603712919710532
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23435,28,1.22 [0.97-1.54],0.0961580920577902
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1525,28,1.25 [0.98-1.60],0.0767336089082673
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",21938,28,1.22 [0.97-1.54],0.0912485697914622
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23050,80,0.98 [0.74-1.28],0.8708536701906253
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23013,43,0.97 [0.69-1.37],0.8665192265454534
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22926,76,0.95 [0.80-1.13],0.5689847302786057
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23159,88,0.93 [0.78-1.11],0.4157316939467008
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23546,110,1.06 [0.94-1.20],0.3560850448302012
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22970,93,0.89 [0.73-1.09],0.2544999209087369
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17378,2353,1.00 [0.96-1.05],0.946629519215012
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23175,65,1.08 [0.88-1.31],0.4620691813851281
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18294,1726,1.02 [0.97-1.08],0.4725928029605901
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertension,18309,1741,1.03 [0.97-1.08],0.3258492535579003
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16602,34,1.41 [1.17-1.68],0.0002121491597609
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22235,616,0.94 [0.84-1.05],0.2586212450995365
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Angina pectoris,22046,427,0.98 [0.87-1.11],0.7579221447692663
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23079,123,0.77 [0.57-1.03],0.0805149620425671
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23147,191,0.90 [0.73-1.10],0.3034563914479444
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23593,25,1.03 [0.62-1.70],0.9118039456767087
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21700,81,1.02 [0.78-1.33],0.9077546887590884
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22003,395,0.90 [0.77-1.04],0.1546000560413879
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22974,83,1.02 [0.84-1.23],0.8541446228571126
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23073,185,1.01 [0.89-1.15],0.8440538796243662
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22981,90,0.88 [0.69-1.13],0.3226717979734537
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22981,90,0.88 [0.69-1.13],0.3226717979734537
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16655,87,0.91 [0.71-1.16],0.4477546741389445
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20566,31,0.97 [0.62-1.52],0.908080010796924
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Conduction disorders,20598,63,0.84 [0.60-1.17],0.3046250557879195
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14211,83,1.08 [0.93-1.25],0.3245831639824755
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14360,232,1.16 [1.02-1.31],0.0254385034525189
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20578,43,0.85 [0.58-1.24],0.4015519254278864
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20584,49,0.86 [0.60-1.23],0.4147563422133268
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22948,84,1.30 [1.09-1.55],0.0033593634966764
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22984,110,1.08 [0.95-1.23],0.2513453638554546
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23019,82,1.06 [0.90-1.26],0.4636432436282425
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23079,70,1.04 [0.86-1.26],0.6748487642928813
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22793,60,1.07 [0.88-1.30],0.5135056755701979
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22828,95,1.04 [0.89-1.22],0.5844628548868427
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22273,112,0.99 [0.84-1.17],0.9194682322032696
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22250,89,0.99 [0.83-1.19],0.9379665677643656
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23464,88,0.99 [0.83-1.19],0.9194613939337772
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Varicose veins,22685,524,1.03 [0.96-1.09],0.4109149359931734
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypotension,22708,73,1.06 [0.88-1.27],0.5261201628223863
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19223,1821,1.01 [0.98-1.05],0.5184827843380316
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23467,112,1.00 [0.89-1.12],0.9945297369578584
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22252,179,1.09 [0.99-1.21],0.0845918792410787
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22235,162,1.11 [0.99-1.23],0.070663870167373
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22856,204,0.95 [0.83-1.07],0.3964218810871081
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22851,199,0.95 [0.84-1.08],0.4347097891412184
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22991,484,0.97 [0.91-1.04],0.4291507470509095
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22610,103,0.82 [0.66-1.01],0.062814297268481
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Nasal polyp,22578,71,1.04 [0.87-1.25],0.6648019497432534
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22814,307,1.00 [0.92-1.08],0.9627583531390344
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22628,121,0.96 [0.84-1.10],0.5458213137728567
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11356,56,1.10 [0.93-1.31],0.257909608803836
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21083,1004,1.01 [0.96-1.06],0.6438479798604351
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Early onset COPD,22751,136,1.00 [0.84-1.18],0.960971226418206
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22768,153,1.02 [0.86-1.21],0.8479001887216244
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22768,153,1.02 [0.86-1.21],0.8479001887216244
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21856,859,0.99 [0.94-1.04],0.7394809002478219
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Asthma,17551,859,1.00 [0.95-1.05],0.970426923364296
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17391,859,1.00 [0.95-1.05],0.9918604152573144
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17539,847,1.00 [0.95-1.05],0.9803487022416774
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23368,79,0.91 [0.70-1.17],0.4572274637188915
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22074,61,0.92 [0.69-1.22],0.5531636976632802
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23430,61,0.92 [0.69-1.22],0.5448018728594961
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22067,54,0.94 [0.69-1.27],0.6719882769488605
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural effusion,22063,74,1.03 [0.87-1.23],0.7053569565473109
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22156,167,1.05 [0.94-1.17],0.3943375581980138
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22640,79,1.06 [0.90-1.25],0.5032470127134021
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16435,5168,1.00 [0.97-1.02],0.8038338484075471
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23160,406,1.04 [0.98-1.10],0.2081119126457582
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23613,85,1.02 [0.93-1.13],0.6171478010389673
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impacted teeth,23618,77,1.02 [0.93-1.13],0.6547870420843679
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Dental caries,22848,94,1.08 [0.96-1.21],0.2101867610669406
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22859,105,1.10 [0.98-1.23],0.1028895250038645
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23604,94,1.01 [0.93-1.11],0.7561518969442076
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22849,95,0.88 [0.73-1.07],0.1998636492443875
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22598,66,0.87 [0.66-1.16],0.3443001547841435
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23535,43,0.89 [0.65-1.22],0.4666579246909446
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17893,191,1.06 [0.95-1.19],0.2984019654517307
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19691,1989,1.00 [0.96-1.04],0.9802650036665695
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophagitis,17952,250,1.01 [0.91-1.12],0.8786252919734368
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18349,647,1.03 [0.96-1.10],0.4020830036431487
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17769,67,1.05 [0.89-1.24],0.5630480215710296
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17819,117,1.08 [0.93-1.26],0.3006144173796834
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17735,33,1.27 [0.94-1.72],0.1127905838296034
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastric ulcer,17829,127,1.04 [0.91-1.20],0.558152191501619
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17767,65,1.02 [0.80-1.29],0.8970764918881048
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23572,51,1.01 [0.77-1.33],0.9567353595012208
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic gastritis,17816,114,0.74 [0.56-0.96],0.0246495484348285
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18424,722,1.02 [0.96-1.08],0.5448642118401754
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of appendix,23511,132,0.91 [0.80-1.03],0.1311821100934695
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18197,495,0.98 [0.91-1.06],0.6296261212753593
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17852,150,0.94 [0.80-1.10],0.4601582025606827
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23532,125,1.01 [0.91-1.13],0.8123530732470727
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute appendicitis,23489,110,0.95 [0.84-1.08],0.4331597625332435
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Hernia,21184,1045,0.99 [0.94-1.05],0.8289566555346569
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Inguinal hernia,20197,58,0.99 [0.80-1.23],0.92015215470046
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Umbilical hernia,20206,67,1.12 [0.96-1.30],0.1438964113079259
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ventral hernia,20228,89,0.86 [0.69-1.07],0.1825015441164559
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20974,835,0.99 [0.92-1.06],0.7903361911125267
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22718,793,0.98 [0.92-1.03],0.404801948421897
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18767,1882,0.98 [0.95-1.02],0.4311379777640574
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23356,54,0.93 [0.76-1.14],0.5092250556810142
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23594,77,0.92 [0.78-1.09],0.3449166425757368
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn disease,22002,77,0.92 [0.78-1.09],0.3459747292364316
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21981,56,0.90 [0.74-1.10],0.2891810712958094
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23520,112,0.95 [0.81-1.10],0.4852102201504342
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22037,112,0.95 [0.81-1.10],0.4928250318746786
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22023,98,0.96 [0.82-1.13],0.6633218754197567
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22602,677,0.98 [0.92-1.04],0.5332377196740287
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22592,667,0.98 [0.92-1.04],0.5455821608207749
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16971,86,0.92 [0.74-1.14],0.4342853609503323
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal stricture,23243,86,0.91 [0.73-1.14],0.4180856543303757
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16938,53,0.92 [0.71-1.19],0.5307166205915017
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17465,580,0.92 [0.82-1.03],0.1619782717344756
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17093,208,0.98 [0.88-1.09],0.6946112021129722
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17209,324,0.96 [0.88-1.05],0.4177148580124226
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Constipation,22211,289,0.98 [0.89-1.07],0.6060729762957175
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23202,104,0.94 [0.81-1.10],0.4640079481418873
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16995,110,1.01 [0.91-1.12],0.8776850029415248
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16924,39,0.95 [0.77-1.18],0.6330368089839427
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17663,778,1.00 [0.95-1.06],0.8959783652299015
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestine,17086,201,0.96 [0.83-1.10],0.5621555883716636
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23188,90,0.94 [0.80-1.10],0.4436059644884429
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of liver,22981,89,0.98 [0.81-1.17],0.8053551988152201
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of liver,22939,47,0.90 [0.68-1.20],0.4787542444567007
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22303,743,1.04 [0.98-1.10],0.1660477774384291
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholelithiasis,22181,621,1.01 [0.95-1.08],0.7410985953158531
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholecystitis,21674,114,1.02 [0.88-1.18],0.8207386568729017
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21618,58,1.19 [1.04-1.36],0.010286147273206
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21612,52,1.00 [0.76-1.32],0.989797836194944
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23512,52,0.99 [0.75-1.31],0.9532995750613534
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22470,254,1.05 [0.96-1.14],0.3136721010106428
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22302,86,1.05 [0.91-1.22],0.4755409059883763
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Coeliac disease,22289,73,1.06 [0.90-1.25],0.4620316467057307
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22250,34,0.78 [0.54-1.12],0.182377766580391
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22355,139,1.09 [0.97-1.22],0.1519715782146085
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,GI-bleeding,22347,131,1.09 [0.97-1.23],0.1268584099293214
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20932,1381,0.98 [0.94-1.03],0.4391606127834732
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23254,103,1.07 [0.93-1.22],0.3399560481476062
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23269,386,1.00 [0.93-1.08],0.9753085545595604
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22282,590,0.96 [0.89-1.02],0.1879659648687297
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22933,283,1.00 [0.91-1.09],0.9404265779428144
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22713,63,0.95 [0.81-1.12],0.5367825120754479
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22833,183,0.99 [0.88-1.13],0.9197058820287676
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23391,74,0.99 [0.83-1.19],0.919695635888345
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23370,53,1.02 [0.85-1.24],0.8072445473510846
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23358,41,1.04 [0.84-1.28],0.7099503042242316
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23428,48,0.97 [0.73-1.30],0.83740876254003
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23425,45,0.98 [0.73-1.31],0.8992413000243153
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22934,51,1.02 [0.83-1.26],0.8395341118151207
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23183,300,1.02 [0.94-1.10],0.7153650120968562
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21777,85,1.00 [0.84-1.20],0.9717876565517328
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21822,130,0.90 [0.76-1.06],0.1932828965975387
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21788,96,0.87 [0.72-1.06],0.1635306672947868
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21910,218,0.95 [0.85-1.06],0.3840169282158513
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21889,197,0.90 [0.79-1.03],0.1214931742095963
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16663,3797,0.97 [0.94-1.00],0.0633158712396452
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18165,2185,0.98 [0.95-1.03],0.4676388625730202
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21227,1144,0.95 [0.90-1.00],0.0390055058419397
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16173,193,1.05 [0.95-1.17],0.3273323802734482
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16432,452,0.99 [0.91-1.07],0.7559508960191731
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23151,185,1.05 [0.95-1.17],0.3459810953742008
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23165,170,1.05 [0.93-1.17],0.4422272929704834
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17026,1046,0.95 [0.88-1.03],0.2251396976443771
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19371,1046,0.96 [0.89-1.03],0.2669414610019521
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15992,12,1.34 [0.87-2.05],0.1807235697144155
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23491,12,1.34 [0.87-2.06],0.1836775846630961
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16211,231,0.86 [0.72-1.02],0.0854451489198954
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16056,76,0.99 [0.73-1.34],0.9527359859938904
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16243,263,0.90 [0.75-1.09],0.2716906679945411
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23470,133,0.89 [0.68-1.16],0.3793700172088805
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16387,407,0.97 [0.86-1.08],0.5682794456723499
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16389,409,0.97 [0.86-1.09],0.6346175591898581
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17201,1221,0.97 [0.93-1.02],0.3101725383148496
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16078,98,nan [nan-nan],
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16337,357,0.99 [0.90-1.09],0.8751972423486563
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16047,67,0.82 [0.57-1.20],0.3073829333213124
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16071,91,1.00 [0.79-1.28],0.9954339654059328
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16301,321,0.89 [0.80-0.99],0.0368432251022319
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16252,272,0.88 [0.78-1.00],0.0575736893887036
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17608,256,1.05 [0.96-1.14],0.3034825639208689
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22922,206,0.98 [0.90-1.08],0.7480220022824231
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22799,83,1.02 [0.85-1.23],0.7976188890270381
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20232,76,0.99 [0.79-1.23],0.8977980541319844
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20423,267,1.01 [0.90-1.13],0.9225815930432092
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21053,897,0.97 [0.92-1.02],0.2147534538287412
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20340,184,1.02 [0.89-1.17],0.7291330702864108
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20223,67,1.04 [0.82-1.31],0.7542233759121244
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20872,716,0.97 [0.92-1.03],0.2770898216191133
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20198,42,0.98 [0.79-1.22],0.8608712802616166
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20371,215,0.93 [0.83-1.04],0.1863193039959048
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20248,92,0.93 [0.79-1.10],0.3804129838416845
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20231,75,1.03 [0.86-1.24],0.7295105202353678
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20286,130,1.02 [0.91-1.14],0.7435242356402401
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20226,70,0.81 [0.64-1.04],0.0973001184116154
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20466,310,0.99 [0.91-1.07],0.7738883396972179
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20416,333,0.96 [0.87-1.06],0.4081337574304527
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20146,63,0.85 [0.62-1.15],0.2927092348297013
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20177,94,1.05 [0.87-1.27],0.624564581219433
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20204,121,0.98 [0.86-1.12],0.7478903010370124
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20119,36,0.96 [0.74-1.23],0.7364481297903019
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20133,50,0.95 [0.72-1.24],0.6935457267290532
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20120,37,0.96 [0.64-1.44],0.8455176222038732
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20311,228,0.94 [0.83-1.06],0.3028480464947006
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20134,51,0.99 [0.79-1.25],0.935803214320726
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20136,53,1.05 [0.81-1.36],0.7161400964268683
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20196,113,0.94 [0.80-1.11],0.4546708378283356
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20152,69,0.95 [0.79-1.14],0.6001535467686917
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20550,467,0.95 [0.89-1.03],0.2148339035491702
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20249,166,0.95 [0.83-1.08],0.437470302420015
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20336,253,0.95 [0.86-1.05],0.3501499568234897
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21286,212,0.95 [0.81-1.11],0.5002112470229912
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21488,414,0.97 [0.88-1.05],0.4381471631786807
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21107,33,0.68 [0.42-1.11],0.122571866069018
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21123,49,1.07 [0.90-1.28],0.4438555041407652
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21165,91,1.02 [0.89-1.17],0.7872426934892476
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19409,5282,0.97 [0.95-0.99],0.0052632920960594
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21655,158,1.07 [0.97-1.19],0.1898680888098054
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21536,39,1.02 [0.82-1.27],0.8763447483723821
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21820,26,1.16 [0.90-1.50],0.2433603058593466
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21824,30,1.29 [1.06-1.57],0.011676870665202
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21827,33,1.13 [0.91-1.39],0.2621477325942372
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23440,109,1.04 [0.92-1.17],0.577624026895794
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23343,53,0.86 [0.64-1.17],0.341388503692755
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23413,82,1.08 [0.94-1.22],0.2747482465082637
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23362,31,1.08 [0.89-1.31],0.4148620434525606
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21784,1087,0.99 [0.94-1.04],0.5552006047133482
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cystitis,20805,108,0.95 [0.80-1.13],0.5484847802039909
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20773,76,1.04 [0.87-1.25],0.6376253808127289
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20836,139,0.81 [0.65-1.01],0.0630834229705482
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20778,81,1.00 [0.85-1.19],0.9616724245943156
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21557,860,1.00 [0.95-1.06],0.8603767530128641
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23387,416,0.99 [0.92-1.06],0.6839756863434718
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23101,130,0.95 [0.82-1.09],0.4322873936344195
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23115,144,0.99 [0.88-1.12],0.8599987827272593
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23069,98,1.06 [0.92-1.21],0.4194232423303493
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23325,482,0.96 [0.90-1.01],0.1183238646478733
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22960,117,0.89 [0.77-1.04],0.1342066019314756
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23057,214,0.93 [0.86-1.01],0.0912681056815153
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21580,3947,0.94 [0.92-0.97],8.932022075887561e-06
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17931,298,0.87 [0.81-0.94],0.0005234251819051
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17714,81,0.82 [0.71-0.95],0.0073676853442662
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17774,141,0.92 [0.82-1.03],0.1643973238200387
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18315,682,0.98 [0.91-1.05],0.5785228571770634
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17981,348,0.88 [0.82-0.95],0.0011521215602942
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18453,820,0.91 [0.86-0.97],0.0045355373192167
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17902,269,0.89 [0.80-1.00],0.0444178776146804
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18013,380,0.95 [0.88-1.04],0.2676378308326284
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17721,88,0.89 [0.78-1.02],0.1077536280212562
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17801,168,1.00 [0.92-1.08],0.9927205208043606
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23613,229,1.02 [0.95-1.09],0.6555357712795058
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23624,217,1.02 [0.95-1.09],0.6118023537367118
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23645,116,1.01 [0.92-1.10],0.8555367558717428
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23635,128,1.00 [0.92-1.10],0.9182954484412096
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17761,128,0.92 [0.78-1.07],0.268947042576363
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17737,104,0.92 [0.78-1.08],0.2873217285596994
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17757,124,1.03 [0.92-1.16],0.604677022594448
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23558,396,0.94 [0.88-1.00],0.0540038240087121
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18791,1158,0.92 [0.89-0.96],1.6638660284166663e-05
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18394,761,0.91 [0.87-0.95],5.579146255685842e-05
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23633,172,0.88 [0.79-0.98],0.0238317172012325
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18035,402,0.92 [0.86-0.99],0.0169692496890253
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17902,269,0.93 [0.86-0.99],0.0309192193538119
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18406,773,0.85 [0.77-0.95],0.0024188164682257
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female infertility,17716,83,0.96 [0.87-1.05],0.3238973554607484
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17709,76,0.98 [0.89-1.07],0.6325303636861691
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23640,718,1.02 [0.99-1.05],0.152717692677475
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23646,985,1.04 [1.01-1.06],0.0116461009487979
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23640,379,1.04 [1.00-1.08],0.0431663626754347
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23368,107,0.99 [0.92-1.07],0.8717686121045003
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23408,147,1.06 [0.99-1.12],0.0735739653473716
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23398,137,1.05 [0.98-1.12],0.1384146305225728
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23657,143,0.95 [0.89-1.02],0.1747687272847702
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23659,140,0.95 [0.88-1.02],0.1438189644806501
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23657,352,1.01 [0.97-1.05],0.6671002216143628
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23409,104,0.93 [0.86-1.01],0.0980808667775932
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23501,196,1.05 [1.00-1.11],0.0607329792704998
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23045,123,1.00 [0.94-1.07],0.8939221308947485
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23087,165,0.99 [0.93-1.06],0.83033325388616
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23122,200,1.03 [0.97-1.08],0.3409664822566471
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23043,121,0.97 [0.90-1.04],0.3654413806678122
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,23034,112,1.00 [0.93-1.07],0.9744847103683782
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23048,126,1.02 [0.95-1.09],0.6094468231941264
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22845,184,1.02 [0.97-1.08],0.4500027634305488
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23025,364,1.03 [0.99-1.07],0.1667592544997327
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23209,548,1.04 [1.01-1.08],0.0237332935331071
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23661,144,1.05 [1.00-1.12],0.0697959167707425
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22466,110,1.07 [1.00-1.14],0.0474528351937089
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22744,83,1.04 [0.97-1.13],0.2683310399419233
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23667,279,1.05 [1.01-1.10],0.0225211709923417
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23604,216,1.07 [1.02-1.12],0.0088286947965092
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23656,214,1.01 [0.96-1.07],0.6287597496976878
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23646,204,1.01 [0.96-1.07],0.6209090404415214
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23410,40,1.05 [0.78-1.43],0.7363864000676813
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21189,531,0.98 [0.90-1.06],0.5897378063852126
